A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity

Xiaoyu Ding(Capital Medical University)
EBioMedicine
September 16, 2020
Cited by 13


Related Papers